Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Stem cells may halt chronic kidney disease
Siamese cat
Researchers hope stem cell therapy may improve organ function in cats with advanced kidney disease.
US researchers launch new clinical trial for cats in advanced stages of disease

Stem cell therapy may be able to slow the progression of kidney disease in cats, US researchers say. A new clinical trial could even have wider implications for human medicine.

Previous studies at Colorado State University (CSU) found stem cells could stabilise the kidneys for cats with early stages of the disease.

A few of the cats with more advanced disease also appeared to benefit, however, showing limited disease progression years after receiving treatment. Encouraged by these results, the research team is now recruiting patients with stage four chronic kidney disease.

"We can't ignore the possibility that stem cells could help those cats too," said Jessica Quimby, leading the research.

Chronic kidney disease is common in older cats but the risk factors are poorly understood and other than a kidney transplant, there is no cure.

Stem cell therapy cannot reverse the kidney scarring that occurs in the later stages of the disease, but CSU researchers hope it may improve the overall function of the kidneys.

Shelley McCarron enrolled her six-year-old Siamese cat Baxter on a CSU study last year. She said: "I believe the treatments have stabilised his kidneys rather than restoring them, but we're grateful nonetheless. It's certainly better to be stabilised than continue to decline".

Patients in the trial will be given three stem cell injections, two weeks apart. Diagnostic tests will be carried out by veterinary surgeons before, during and after the treatment to determine the effect.

Dr Quimby said the research could one day benefit human health, as the disease progresses in a similar way in both humans and cats. "Kidney disease is indeed a huge and growing problem in human medicine. If we saw improvement with cats, we could relate it to curing humans".

Much of the trial costs are covered by Frankie's Fund for Feline Stem Cell Research. The fund was named after a seal point Siamese cat that helped CSU pioneer their stem cell research in 2009. A photo of Frankie is hung in Dr Quimby's office as a reminder of the hope offered by the treatment.

CSU researchers are seeking patients with stable, stage four chronic renal disease. Cats with other diseases will not be eligible. For more information, visit the clinical trial website.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.